CHANGE IN RATINGS
upgraded at Merrill/BofA from Underperform to Neutral. $22 price target.
upgraded at Morgan Stanley from Equal-weight to Overweight. $81 price target.
Check Point Software
upgraded at Goldman Sachs to Neutral from Sell. Price target raised to $22 from $19.
downgraded at Goldman Sachs to Sell from Neutral. Price target unchanged at $29.
upgraded at J.P. Morgan to Overweight.
downgraded at Deutsche Bank to a Hold from a Buy and price target maintained at $38. 2009 estimate reduced below consensus to $2.97.
upgraded at Citigroup from Hold to Buy. $42 price target.
downgraded at RBC to Sector Perform from Outperform. Price target raised to $39 from $35.
downgraded at Deutsche Bank to Sell from Hold and price target reduced to $73 from $83.
downgraded at Goldman Sachs to Neutral from Buy. Price target lowered to $64 from $71.
downgraded at Barclays to Underweight from Equal-weight. Target price lowered to $10 from $12. Maintains 2008 EPS estimate of $1.28.
downgraded at Deutsche Bank to a Hold from a Buy and price target unchanged at $34.
downgraded at Merrill/BofA from Neutral to Underperform. $8 price target. Estimates also cut.
Martin Marietta Materials
downgraded at UBS to Sell from Neutral. Price target raised to $82 from $75. Maintains 2008 EPS estimates of $4.20.
downgraded at J.P. Morgan to Neutral.
downgraded at Goldman to Sell from Neutral. Price target at $18.
downgraded at Morgan Stanley from Overweight to Equal-weight.
upgraded at Goldman Sachs to Buy from Neutral. Price target raised to $57 from $53.
downgraded at Deutsche Bank to Hold from Buy. Stock has reached its target price of $14.
upgraded at Smith Barney to Hold from Sell. Price target raised to $28 from $16. Raises fiscal 2009 EPS estimates to $2.73 from $2.34.
downgraded at Morgan Stanley from Equal-weight to Underweight. $37 price target. Estimates also cut.
STOCK COMMENTS / EPS CHANGES
numbers raised at Barclays. Shares now seen reaching $95. Estimates also boosted to reflect higher sales and enrollment in the most recent quarter. Overweight rating.
numbers cut at Citigroup. Shares now expected to reach $29. Estimates also lowered. Buy rating.
added to Top Picks list at Citigroup. Buy rating and $73 price target.
numbers lowered at Barclays. Shares now seen reaching $35. Estimates also cut to reflect lower sales and margins in the latest quarter. Overweight rating.
numbers cut at UBS. Shares now seen reaching $9. Estimates also lowered to match the company's new guidance. Neutral rating.
numbers cut at Barclays. Shares now seen reaching $21. Estimates also lowered to reflect negative expected commodity prices and higher financing costs. Equal-weight rating.
numbers lowered at UBS. Shares now seen reaching $61. Estimates also cut, to reflect weaker sales and higher costs in recent months. Buy rating.
This article was written by a staff member of TheStreet.com.